Literature DB >> 25030330

Calcific embolization with infective endocarditis involving the posterior mitral leaflet in a patient with underlying hypertrophic obstructive cardiomyopathy.

Navneet Lather1, Kyle Niziolek, Peter Toth, David M Harris.   

Abstract

We report a case of infective endocarditis (IE) involving the posterior mitral leaflet (PML) with calcific embolization in a patient with hypertrophic obstructive cardiomyopathy (HOCM). Amongst HOCM patients with IE, the anterior mitral leaflet and basal septal myocardium are almost always involved due to the endocardial damage caused by recurrent outflow obstruction and valvular regurgitation. The management of our patient was complicated by moderate mitral stenosis, repeated calcific embolic strokes, dynamic left ventricular outflow track obstruction, and respiratory failure due to flash pulmonary edema. To our knowledge, this is the first reported case of PML involvement in HOCM presenting in this manner.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25030330     DOI: 10.1007/s11239-014-1111-4

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  13 in total

Review 1.  Management of symptoms in hypertrophic cardiomyopathy.

Authors:  Michael A Fifer; Gus J Vlahakes
Journal:  Circulation       Date:  2008-01-22       Impact factor: 29.690

2.  ACC/AHA 2008 Guideline update on valvular heart disease: focused update on infective endocarditis: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons.

Authors:  Rick A Nishimura; Blase A Carabello; David P Faxon; Michael D Freed; Bruce W Lytle; Patrick T O'Gara; Robert A O'Rourke; Pravin M Shah
Journal:  J Am Coll Cardiol       Date:  2008-08-19       Impact factor: 24.094

3.  Clinical and hemodynamic results after mitral valve replacement in patients with obstructive hypertrophic cardiomyopathy.

Authors:  C L McIntosh; G J Greenberg; B J Maron; M B Leon; R O Cannon; R E Clark
Journal:  Ann Thorac Surg       Date:  1989-02       Impact factor: 4.330

Review 4.  Magnetic resonance imaging for hypertrophic cardiomyopathy update.

Authors:  Andy Kar Wai Chan; Bhanusupriya Somarouthu; Brian Ghoshhajra
Journal:  Top Magn Reson Imaging       Date:  2014-02

Review 5.  Prevention of infective endocarditis.

Authors:  D T Durack
Journal:  N Engl J Med       Date:  1995-01-05       Impact factor: 91.245

6.  Infective endocarditis complicating hypertrophic obstructive cardiomyopathy.

Authors:  Taoufik Louahabi; Abdenasser Drighil; Rachida Habbal; Leila Azzouzi
Journal:  Eur J Echocardiogr       Date:  2005-10-24

7.  Long-term effects of dual-chamber pacing with periodic echocardiographic evaluation of optimal atrioventricular delay in patients with hypertrophic cardiomyopathy >50 years of age.

Authors:  Ian Topilski; Jack Sherez; Gad Keren; Itzchak Copperman
Journal:  Am J Cardiol       Date:  2006-05-03       Impact factor: 2.778

Review 8.  Bacterial endocarditis complicating mitral annular calcification: a clinical and echocardiographic study.

Authors:  Jean-Christophe Eicher; Laurence De Nadai; Francois-Xavier Soto; Sylvie Falcon-Eicher; Petr Dobsák; Gilbert Zanetta; Jean-Michel Petit; Henry Portier; Pierre Louis; Jean-Eric Wolf
Journal:  J Heart Valve Dis       Date:  2004-03

9.  Clinical significance of late gadolinium enhancement in patients<20 years of age with hypertrophic cardiomyopathy.

Authors:  Brandon M Smith; Adam L Dorfman; Sunkyung Yu; Mark W Russell; Prachi P Agarwal; Maryam Ghadimi Mahani; Jimmy C Lu
Journal:  Am J Cardiol       Date:  2014-01-15       Impact factor: 2.778

10.  Infective endocarditis in hypertrophic cardiomyopathy: prevalence, incidence, and indications for antibiotic prophylaxis.

Authors:  P Spirito; C Rapezzi; P Bellone; S Betocchi; C Autore; M R Conte; G P Bezante; P Bruzzi
Journal:  Circulation       Date:  1999-04-27       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.